Secured Declination for SPAC Target in SEC and DOJ Investigations

Represented the target life sciences company in a SPAC transaction in SEC and DOJ investigations regarding the SPAC’s failure to include millions of dollars in contingent liabilities on its financial statements and pro formas. No enforcement action was taken.